What Brings Us Happiness? Panasonic Answered Through "Robotics for Well-Being" Webinar

▲ Panasonic's panel session with a theme of "Robotics for Well-Being" was held as a webinar due to the cancellation of SXSW 2020. (Image from Panasonic website) Due to COVID-19, the world's largest content festival, SXSW 2020, which was scheduled to be held in Austin, Texas, from March 13 to 22, has been canceled. However, as everything is being digitalized, on the morning of April 9, the "Robotics for Well-Being" Panel Session hosted by Panasonic was held as a webinar through the video conferencing service Zoom. The speakers of the session were Takeshi Ando, Head of the Panasonic Aug Lab, Ann Greenberg, CEO of Entertainment AI, and Harold E. Puthoff, CEO of EarthTech International. Each speaker commented on how technology can help business, science, and entertainment combine and create new solutions to make human's lives happier. They discussed how to understand reality and enrich experiences through "human-centered storytelling" and technical solutions. The session also presented how AI, robots, and human assist devices can bring happiness at the physical, emotional, and social levels. ▲ Takeshi Ando, Head of the Panasonic Aug Lab ▲ "Babypapa" for families with babies (Image from Panasonic website) Panasonic Aug Lab, which Takeshi Ando belongs to, is a division that researches ways to improve the quality of life using AI and technology. He introduced the works going on in this lab. First, Tomato Harvesting Robots and Delivery Robots that deliver goods while avoiding obstacles safely in hospitals, etc., were mentioned to explain that it is possible to improve productivity and efficiency through automation. Also, he showed a wheelchair for patients with cerebral palsy, which was conducted at Waseda University in 2010 by him. He said that it brought great happiness to patients and their families.Ando showed the graphs of GDP and life satisfaction in Japan and the US. In the graphs, GDP continues to rise, but life satisfaction remains the same or gets worse in both Japan and the US. So, "It is not just Japan's problem. It is a global problem. We need augmentation through automation with robots," he said. The word 'Augmentation' in the Panasonic Aug Lab is an effort to enrich life and add happiness. He also stated that well-being requires efforts in physical, emotional, and social levels.As a prototype that can bring well-being from all those aspects, Babypapa, was introduced. Babypapa is a robot developed for families with babies. It helps children who are alone to be bored, to observe facial expressions, take pictures of the most beautiful and precious moments, and improve social experiences. Ando explained that Babypapa makes it possible to share sincere and steady emotional sympathy without forcing communication. He also added that it is okay to use only one, but if three units are used, they can work together to create a better synergy effect."More than 700 ideas are coming out of the Panasonic Aug Lab, and about 20 projects are in progress. Panasonic strives not only for social well-being but also for individuals'. As COVID-19 isolated people and we are all in a physically and mentally debilitating state, it is time to develop new technologies using AI, 5G, and robots," said Takeshi Ando. ▲ Ann Greenberg, CEO of Entertainment AI ▲ Ann Nonymous™ advocates for a high tech-future as a virtual human. A pioneer of digital media who developed the democratization of media, Ann Greenberg first introduced her company, Entertainment AI (or Sceneplay Inc.). Entertainment AI is a smart content company that enables users to appear in content along with their friends and favorite creators and gets all participants paid through the automation of media creation. The automation could be done by using Smart Script, which is a tool that generates smart content. The smart content can be personalized according to the needs of users after micronizing the content and making every element cryptographically secure. Ann emphasized Hyper-personalization' and Human-centered Storytelling. Hyper-personalization can be realized through the smart content provided by Entertainment AI, and it changes depending on who the user is and what they want with any media such as live actions, animations, puppets, and even robots. And when it comes to Human-centered Storytelling, she explained that it corresponds to the ultimate goal of Entertainment AI and said: "We are all protagonists in the story of our lives, and anyone can be a creator." Ann introduced the prototype, Ann Nonymous, which is currently being studied at the company. She explained that Ann Nonymous is the world's first collaborative virtual human and influencer based on Entertainment AI's "Big Sister" platform. The Big Sister platform is contrary to the term "Big Brother," which originated in British novelist George Orwell's "1984." Moreover, she added that it advocates for a high tech-future with a human heart. "Technology will help overcome the limitations of social distance and communication caused by COVID-19. As the age of co-creation is approaching, it will be possible to create a society of more advanced technology by harmonizing robots and various creativity that humans can create," said Ann Greenberg. ▲ Harold E. Puthoff, CEO of EarthTech International ▲ To The Stars Academy (TTSA) is working on a lot of research to improve social well-being. (Image from TTSA website) Founder of EarthTech International and physicist of Stanford Research Institute, Harold E. Puthoff introduced himself as "a someone who always stands at the intersection of Biology, Physics, and Technology with passion for searching for solutions to impossible problems and opportunities where others see difficulties." Then, he cited the Casimir Effect, which is caused by the quantum-theoretic effect of vacuum, to explain that any new kind of energy source with potential will power micro-devices that assist humans in achieving harmony with nature and with each other, like Casimir force. Moreover, Puthoff explained Secure Communication as a technique that can be explained through quantum physics theory. The electromagnetic field that we are currently using in Wi-Fi or radio is affected by geophysical factors, plasma, water, etc., but as for Electromagnetic Potential of quantum physics, even electromagnetic shielding cannot be a barrier. He said that this new form of secure and private communication could provide stability in our lives.He then referred to the Brain-Machine Interface (BMI) developed by Stanford University as an example of the micro-devices mentioned above. This interface is a device that translates neuronal information into commands capable of controlling external software or hardware such as a computer or robotic arm. "Tapping, understanding, and manipulating brain waves and synaptic energy will enhance emotional, physical, and social human well-being," said Puthoff.Lastly, Puthoff introduced To The Stars Academy of Arts & Science (TTSA). He co-founded TTSA with Tom DeLonge, and many scientists are working to create a more advanced society and open new paths at TTSA. It focuses on collecting and researching anomalous data to develop technologies. In particular, its entertainment division aims to tell people complex and challenging scientific theories and techniques with easy and fun stories.

Osang Healthcare Received Emergency Use Authorization (EUA) by USFDA For COVID-19 Test Kit

Osang Healthcare, a subsidiary of OsangJaiel, announced that it obtained emergency use authorization (EUA) by the US Food and Drug Administration (FDA) on its COVID-19 test kit, GeneFinder™ COVID-19 Plus RealAMPKit. Osang Healthcare is a South Korean manufacturer and distributor of medical devices. As the excellence of Korean test kits became known, competition around the world is fierce to secure Korean test kits. Currently, more than 100 countries have imported Korean COVID-19 test kits. With this FDA's EUA approval of Osang Healthcare, it is expected that the proportion of test kits in exports will increase significantly. Osang Healthcare has begun negotiations to export to the US market in earnest through this EUA approval. Currently, specific discussions are underway for large-scale export contracts related to the supply of COVID-19 test kits to various channels in the United States. Recently, the company has signed large-scale export contracts with Brazil, Russia, Italy, Romania, Morocco, Argentina, and the Federal Emergency Management Agency (FEMA). Besides, it is currently responding to export inquiries from over 70 countries around the world, and the produced quantity is shipped every week. The company stated, "We already have expanded the production capacity so that there is no problem in supplying test kits in preparation for additional large-scale orders from the United States, South America, Europe, and the Middle East."

POSTECH Developed Smart Contact Lens for Diabetes Monitoring and Diabetic Retinopathy Therapy

Diabetes is called an "immortal disease" as it is never completely removed with any treatment of modern medical science once it develops. But what if you could control the secretion of insulin just by wearing contact lenses? Recently, POSTECH (Pohang University of Science and Technology) research team developed a wireless smart contact lens technology that can diagnose diabetes by wearing contact lenses and can even treat diabetic retinopathy by itself. The smart contact lens can diagnose and treat diabetes by controlling drug release with electrical signals. It is made of biocompatible polymers and incorporates biosensors, drug delivery systems, and data communication systems. The research team confirmed that the sugar concentration in tears analyzed by the smart contact lens in the diabetic rabbit model is consistent with the blood sugar analyzed by the conventional glucose meter and that the drug in the smart contact lens can be used to treat diabetic retinopathy. In recent years, by utilizing such smart contact lens-based technology, researches are being conducted to broaden the scope of use as an electronic drug system that can treat mental disorders by electrical stimulation. Mental disorders include depression and brain diseases such as Alzheimer's and Parkinson's disease. The research team expects that smart contact lenses for self-controlled treatment, along with real-time bio-analysis, will be developed and quickly applied to wearable healthcare-related industries. The findings were published in the world-wide journal, Science Advances.

• 

  AACR Led Global Cooperation to Resolve Questions About Relationship Between Cancer Patients and COVID-19

  (Image from: AACR) Due to COVID-19, the American Cancer Society (AACR) decided to hold annual meetings online. AACR Virtual Annual Meeting 2020 takes place on two separate occasions, April 27-28 and June 22-24. On the first day, the 27th, there were mainly presentations on current or completed bio-clinical trials. On the 28th, the meeting was started with the plenary session on the subject of <COVID-19 and Cancer>, followed by symposiums and general meetings on new drugs and treatments under development. The virtual plenary session <COVID-19 and Cancer>, which was held at 9 AM EDT, consisted of 7 presentations. In each presentation, the status of COVID-19 and various statistics on cancer patients in major countries and cities around the world, such as Wuhan, Milan, Paris, Madrid, Naples, and New York, were revealed, and their views and opinions were also shared. The following are the six presentations presented after Prof. Li Zhang of Tongji Medical College in the first order, <The experience of treating patients with cancer during the COVID-19 pandemic in China>. Marina Chiara Garassino, MD, from Istituto Nazionale dei Tumori in Milan, gave a presentation about <TERAVOLT: First results of a global collaboration to address the impact of COVID-19 in patients with thoracic malignancies>. TERAVOLT researched 200 patients with COVID-19 and thoracic cancers from 8 countries. As a feature of the findings, the mortality rate was 34.6%, and most of the deaths were due to COVID-19, not cancer. The most frequent complications were pneumonia and acute respiratory distress syndrome (ARDS), and she emphasized that many patients were not offered of ICU admissions mainly due to the shortages and institutional rules. “Tumor type and cancer therapy did not impact survival. Even at multivariate analysis, no factors were associated with risk of death. As the cancer diagnosis patients with thoracic malignancies are less likely to be admitted to the intensive care unit, they are at increased risk of prolonged hospitalization and mortality from COVID-19 infection,” Garassino stated. “Our study has several limitations such as short follow-up and selected population, but TERAVOLT will continue to collect data and to provide data in order to identify characteristics associated to a severe COVID-19 able to help societies to create guidelines tailored on individual risk.” Fabrice Barlesi, MD, PhD, from Gustave Roussy Cancer Campus Grand Paris gave a presentation with a theme of <Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments>. The research in this presentation was conducted on a total of 7,251 cancer patients managed by Gustave Roussy from March 14 to April 15. As of April 20, 95 (69.3%), 20 (14.6%), and 22 (16.1%) pts were discharged, had died, or were still hospitalized, respectively. Moreover, clinical deterioration occurred in 34 (24.8%) who were associated with hematological underlying disease, CRP at diagnosis of COVID19 or the use of cytotoxic chemotherapy. “Globally, the rate of the SARS-CoV-2 infection in our cancer patients’ population does not seem to be higher compared to the global population. We have not found evidence that COVID19 is more lethal or aggressive in cancer patients that underwent usual SARS-Cov-2 treatment,” Barlesi stated. “Special attention has to be given to frail patients with ECOG>1, hematological diseases, or advanced disease treated with cytotoxic chemotherapy within the last 3 months. We believe that adequate testing and protective measures will justify an optimal management of the cancer patients’ underlying tumor.” Carlos Gomez-Martin, MD, PhD, from University Hospital 12 de Octubre in Madrid, Spain, presented about <Adapting oncologic practice to COVID19 outbreak: From outpatient triage to risk assessment for specific treatment in Madrid, Spain>. From March 9 to April 19, a total of 287 cancer patients were screened, and approximately 26% were confirmed. Data on the first 63 patients were shared through the presentation. More than 80% of patients had metastatic diseases, and 40% had lung-related cancer. The mortality rate was about 25% (16), and lung-related cancer, neutropenia, and acute respiratory distress syndrome were the major risk factors. It was also noted that positive results such as 9 out of 15 patients survived as a result of using the Tocilizumab treatment. “For all patients admitted routine blood test and Chest Xr or CT of the lungs performed previously to been transferred to Ward. Specifics and separate wards for suspected, confirmed and negative coronavirus patients were prepared. Also, all chemo Treatments were reconsidered based on objectives, life expectancy, and type of therapy and clinical status of every patient,” stated Gomez-Martin. “COVID-19 treatment must be multidisciplinary and it should include specific antiviral therapy, supportive treatment, close monitoring of inflammatory parameters, and appropriate use of anticoagulants given the risk of thromboembolic complications in this disease.” Paolo A. Ascierto, MD, from the Istituto Nazionale Tumori IRCCS Fondazione Pascale in Naples, Italy, gave a presentation of <Experience in using oncology drugs in patients with COVID-19>. In the institution to which Ascierto belongs, only two out of 400 patients were confirmed as COVID-19, and all succeeded in receiving a negative test within 10 days using Tocilizumab therapy. Tocilizumab is an anti-IL-6 drug and is known to be effective in patients with cytokine release syndrome. It was also explained that the COVID-19 related acute respiratory stress syndrome is caused by excessive cytokine production. “To keep safe both patients and healthy workers is the most important rule. In our daily practice we adopted a specific policy about the conduct of our clinical managements of melanoma patients, in order to minimize the risk of any potential exposure. We are prioritizing patients, according to the kind of treatment and the stage of disease,” stated Ascierto. “In Italy we started on 19th of March a phase II study (NCT04317092) which enrolled 330 patients in 24 hours, with the ability of tocilizumab to reduce the one-month mortality rate as main endpoint. Besides, we are also conducting clinical study on another anti-IL-6 drug, Sarilumab.” Louis P. Voigt, MD, from Memorial Sloan Kettering Cancer Center in New York gave a presentation about <Flattening the curve but widening disparities>. He first introduced the status of COVID-19 impact on New York State. As of April 22, when fatality was categorized as race/ethnicity, Hispanic (34%) and Black (28%) patients more than 60%. Out of 15,740, the total number of deaths, 14,018 had at least one comorbidity. Hypertension (9,028) was the highest, and the cancer was 1,154. “The proportion of Black and Hispanic was also high in non-hospitalized, non-fatal hospitalized cases, compared to White and Asians. Higher incidence of cancer, higher cancer-related mortality, higher incidence of COVID-19, and higher COVID-19 were related mortality in African American population. But we need to be more careful, because the reality is more complex. We need more time and data,” Voigt stated. “Pandemic create perfect conditions for suboptimal care or deviation from standard care with major impact on the most vulnerable patients. This is because healthcare systems become overwhelmed during pandemic, and decisions are sometimes driven by fear and emotions rather than evolving facts. The most vulnerable among us can fall out of the safety net if we do not pay attention. We need to create more robust safety net.” Last but not least, Hongbing Cai, MD, from Zhongnan Hospital of Wuhan University presented with a theme of <Patients with cancer appear more vulnerable to SARS-COV-2>. Zhongnan Hospital conducted a multi-center study including 105 cancer patients and 536 age-matched non-cancer patients confirmed with COVID-19. According to the study, COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematological cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. In addition, patients who received surgery had higher risks of having severe events, while patients with only radiotherapy did not demonstrate significant differences in severe events when compared to patients without cancer. “These findings indicate that cancer patients appear more vulnerable to SARS-COV-2 outbreak. Since this is the first large cohort study on this topic, our report will provide the much-needed information that will benefit global cancer patients. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients,” stated Cai. “Self-protective isolation, strict in-hospital infection control, and appropriate online medical services are recommended. On top of that, individualized treatment plans need to be developed based on the tumor types and stages of patients by clinicians.”

• 

  Cumulative Quantities of Osang Healthcare COVID-19 Test Kit Exceeded 10 Million

  Osang Healthcare, a South Korean manufacturer and distributor of medical devices, announced that after receiving approval from the FDA on March 18, the cumulative order quantities of COVID-19 test kits had surpassed 10 million. All orders received so far will be shipped later this month. The company has provided COVID-19 test kits to more than 30 countries, including the United States, Brazil, Russia, Italy, Romania, Morocco, Kuwait, and Argentina. In order to export the test kit, it is required to pass the strict technical requirements offered by the FDA in each country. Among them, the U.S. FDA has the highest entry barrier. However, on April 18, the company announced that it obtained emergency use authorization (EUA) by the U.S. FDA on its COVID-19 test kit, GeneFinder™ COVID-19 Plus RealAMPKit. Compared to other EUA-approved products, it has been approved as a universal kit that almost all equipment can use. Thus, the company was able to supply test kits across the United States. "The process of obtaining emergency use authorization, which demands strict technical requirements, had never been easy. I am so proud and happy to be approved by the U.S. FDA for emergency use for the first time in Korea. This is because all employees, such as the dedicated team research center and quality team, worked together in a unified way based on the technology accumulated in the field of diagnostic equipment for 20 years," said Lee Dong-Hyun, CEO of Osang Healthcare. Meanwhile, unlike the competitors that can detect two genes, Osang Healthcare's test kit can identify all three target genes (E, RdRp, N), making the test results highly accurate. Also, as the reagents are user-friendly and efficient, It is highly regarded as a suitable product for mass inspection.

• 

  AbClon Succeeds in Discovering Novel Antibody Drug Candidate for COVID-19

  AbClon, a Korean antibody drug company, stated that it has confirmed the neutralizing capacity to effectively inhibit the infection of COVID-19 from a novel antibody drug candidate discovered from the company's own human antibody library. AbClon has achieved the spike protein of SARS-CoV-2 (COVID-19) and, in particular, several antibodies and affibodies that specifically bind to the receptor-binding domain (RBD) and has applied for patents. The receptor-binding domain is a site that directly binds to human receptors. Among the 20 candidates discovered from the COVID-19 virus neutralizing capacity test conducted by the Korea University Medical Center, AbClone first selected one novel drug candidate that can most effectively neutralize coronavirus and inhibit target cell infection. And the company is now intensively developing the candidate. The coronavirus is RNA-based and is known to easily cause strain. It has already been reported that at least three strains have occurred, and is expected to increase in the future. AbClon is also developing an affibody or AffiMab-type double-antibody using affibodies in order to cope with the coronavirus strains and realize the therapeutic effect applicable to a wide range of patients.

• 

  Seegene Received Emergency Use Authorization (EUA) by USFDA For COVID-19 Test Kit

  Seegene, a Korean company specialized in molecular diagnostics, announced on the 22nd that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Allplex™ 2019-nCoV Assay. Seegene's coronavirus test kit, Allplex™ 2019-nCoV Assay is used worldwide for COVID-19 screening. Since Allplex™ 2019-nCoV Assay can detect all three target genes (E, RdRp, N), it is not only highly accurate, but also can test with only one tube, so it can efficiently perform a large number of tests. Immediately after the occurrence of COVID-19 in China, Seegene quickly began to develop COVID-19 diagnostic reagents using its own AI reagent development system. Seegene's diagnostic reagent technology and automated testing systems have played a pivotal role in effectively controlling the COVID-19 situation in Korea. Seegene Medical Foundation, the affiliated company of Seegene and the largest inspection agency in Korea, can test up to 15,000 COVID-19 tests a day based on the automated testing system. Seegene's testing system has become a global standard for COVID-19 diagnosis and is currently used in more than 60 countries, mainly Italy, Spain, France, and Germany. Having secured an extensive global network and established an excellent reputation through a variety of reagent products, Seegene has been able to quickly apply COVID-19 tests through dedicated testing equipment installed in various places, and it is still generating a great demand from all over the world.

• 

  Chang-Hyeon Kim, Managing Director at JENAX, "Leads the Next Generation of Battery Production Without the Risk of Fire"

• 

  Western Digital Launches 6 New SanDisk Storage Solutions in Korea

• 

  Microsoft held Media Briefing to introduce its IoT Strategy and Prime Cases

• 

  Xilinx-SK Telecom Held Press Conference to Present FPGA-Based AI Accelerator Implementation Cases

• 

  Heilind Asia Wins the “Top 10 Electronic Components Industry Brands Award 2019”

  HONG KONG--(BUSINESS WIRE)--Heilind Asia Pacific, part of Heilind Electronics Inc., was invited to attend Huaqiang Electronic Honor Award Ceremony 2019 held in Shenzhen on 20th May 2020 to meet with the world's leading companies in the electronic components industry. Due to coronavirus, the ceremony was held with live broadcasting. Heilind Asia was presented with the “Top 10 Electronic Components Industry Brands Award 2019”. The ceremony was organized by Elecfans which is an electronic platform with China’s largest community of engineers and electronic semiconductor practitioners. The ceremony has been successfully held for 12 years; it has excellent reputation and popularity in the industry and has become a widely influential electronic component industry event. After several months of selection, over a thousand award nominations, intensive online voting and experts review, finally, Heilind Asia once again won the “Top 10 Electronic Components Industry Brands Award 2019", and was one of the only two international award-winning companies among all the electronic component industry distributors. “I'm honored to accept the Top 10 Electronic Components Industry Brands Award on behalf of Heilind Asia; it represents our new achievements in China electronic component market. Thanks to the organizer and the industry for presenting this award to us, and it gives us motivation to continuingly provide high quality products and extraordinary service to meet the market needs.” said Ken Liu, Branch Manager of Heilind Asia Pacific. Heilind Asia supports both original equipment and contract manufacturers in all market segments of the electronics industry, stocking products from the industry’s leading manufacturers in 25 component categories, with a particular focus on connectors, relays, switches, thermal management & circuit protection products, terminal blocks, wire & cable, wiring accessories, insulation & identification, fastener/hardware and sensor products. About Heilind Electronics: Founded in 1974, Heilind Electronics, Inc. (http://www.heilind.com) is one of the world's leading distributors of connectors, relays, switches, thermal management & circuit protection products, terminal blocks, wire & cable, wiring accessories, insulation & identification, fastener/hardware and sensor products. Heilind has over 40 facilities in the United States, Canada, Mexico, Brazil, Germany, Singapore and China. Heilind Asia Pacific (www.heilindasia.com) commenced operations in Dec 2012, and now has 23 locations throughout Asia. Its industry leading service offering to customers in Asia Pacific is the result of a commitment to the belief of “Distribution As It Should Be”. Learn more at www.heilindasia.com and on Facebook, WeChat, Weibo and Twitter. Contacts Media Heilind Asia Pacific Sarah Luo sarah.luo@heilind.com

• 

  Swiss Education Group Partners Mandarin Oriental Hotel Group to Initiate Research Study On Best Practices for the Global Hospitality Industry

  MONTREUX, Switzerland, May 28, 2020 /PRNewswire/ -- Swiss Education Group, the largest provider of hospitality and culinary education in Switzerland, is collaborating with Mandarin Oriental Hotel Group on a research initiative to study the effects of the ongoing pandemic on the hospitality industry. This project, which also includes leading Swiss industry partners, will identify best practices in crisis management, operations and recovery strategies through interviews, visits and surveys. The findings will be incorporated into the Group's member schools' academic curricula. With five schools based across six campuses throughout Switzerland Swiss Education Group is Switzerlands largest private hospitality educator. Covid-19 has brought unprecedented upheaval on the global economy, and the global hospitality industry is amongst the most affected. As more countries continue to ease lockdowns and travel restrictions caused by the pandemic, this research together with Mandarin Oriental Hotel Group, owner and operator of some of the world's most luxurious hotels, resorts and residences, will focus on how luxury hospitality establishment are managing the crisis. The study will identify best practices and capture valuable learnings during and after the crisis, which will be included in the Group's operational and leadership teaching content. Many questions regarding guest experience, health and safety, technological transformation and changes to operations in the current environment remain real and need to be addressed, and through this research the Group aims to enhance the quality and content of the curricula, making it more relevant for future leaders of the industry. "We have a long standing partnership with Swiss Education Group and are delighted to share relevant learnings and support such a meaningful educational endeavour," said Paul Clark, Chief Human Resources Officer of Mandarin Oriental Hotel Group. Yong Shen, Deputy Chief Executive Officer of the Swiss Education Group added, "The results of the study will be communicated and integrated into our schools' curriculum from September 2020 onwards. This pandemic offers rich learnings for the education of our students as future hospitality business professionals and leaders. We are very pleased to be able to collaborate with Mandarin Oriental Hotel Group and other top Swiss brands including Fairmont Le Montreux Palace and Restaurant de l'Hôtel de Ville Crissier." About Swiss Education Group With five schools based across six campuses throughout Switzerland, Swiss Education Group is Switzerland's largest private hospitality educator. In total, the Group has over 6,000 students from over 110 countries. All schools offer Diploma, Bachelor and Master programmes, with a variety of subjects and specialisations. Contact: seg@cpc-pr.com, +41 (0) 22-552-46-30 Photo - https://mma.prnewswire.com/media/1172997/SEG_five_schools.jpg Logo - https://mma.prnewswire.com/media/1172998/SEG_Logo.jpg Related Links :https://www.swisseducation.com

• 

  World Economic Forum report recognizes key critical infrastructure innovations from Smart Wires, ABB and Siemens

  SAN FRANCISCO, May 28, 2020 /PRNewswire/ -- Today's report from the World Economic Forum's International Energy Community in China has highlighted Smart Wires SmartValveTM as one of the energy sector's influential innovations during the last decade. Winners were chosen based on several criteria including their benefit to society and contribution to accelerating the energy transition. Smart Wires power flow control technology installed at UK Power Networks "Smart Wires is honored that our solutions were included on a very short and prestigious list of technologies recognized as critical enablers of the energy transition," said Gregg Rotenberg, Smart Wires CEO. Suleman Alli, director of strategy at UK Power Networks, said: "As the first network operator in the UK to trial the Smart Wires' power flow control technology, we are delighted to see it recognised by this World Economic Forum report. Trialling smart solutions like load balancing highlights our commitment to unlocking new capacity for renewable energy safely, cost effectively and quickly." Smart Wires was recognized for its ability to maximize the grid's transfer capacity which is necessary to enable rapid, low-cost and large-scale connections of new renewables. Rotenberg reflected, "It is remarkable how much spare capacity exists on today's grids. We regularly find projects where we can release several gigawatts of capacity in under a year without disturbing communities or the environment." "SmartValve is our solution to maximize the grid's transfer capacity. This technology is causing leading utilities across Europe, Australia and the Americas to change the way they think about future investments in critical infrastructure," Rotenberg said. Further Information Submissions were evaluated by a panel of experts from the US, Europe, China and Africa. Selected submissions were grouped into six categories: Critical Infrastructure; Emission Reductions; Energy Efficiency; Systemic Efficiency; Renewables Integration; and Access to Electricity. Smart Wires, ABB and Siemens were highlighted in the Critical Infrastructure category. "Transmission and distribution grids are the backbone of the entire electricity network. Radical changes [from the supply and demand perspective] require our critical electricity infrastructure to be more flexible and agile than ever before, without compromising on power security, reliability, efficiency or affordability. Innovative grid technologies are playing a key role in addressing energy transition-related opportunities and challenges," the report says. ABB was recognized for advances in High Voltage Direct Current (HVDC) technology, supporting the integration of large-scale renewables, off-shore wind farms and cross-border interconnections. Siemens was recognized for its Modular Multilevel Converter (MMC) technology, representing a technological breakthrough when connecting large offshore wind parks to the grid. These innovations have proven themselves over the past decade and will continue to be pivotal to enable a successful, low-cost and low-impact energy transition. About Smart Wires: Smart Wires develops and implements innovative technologies that advance the delivery of electricity. With our technology, electric utilities can maximize transfer capacity on their grids. This means more renewables, improved flexibility and stability, and less constraints, costs, community and environmental impact. With our next generation SmartValve™ technology, alongside our advanced analytics and consulting services, we are built to assist utilities solve problems and evolve the grid. (www.smartwires.com). About UK Power Networks: UK Power Networks is the country's biggest electricity distributor, making sure the lights stay on for more than eight million homes and businesses across London, the South East and the East of England. Network operators aren't the same as energy suppliers; network operators manage local power lines and substations, while energy suppliers sell the electricity that runs through the power lines. UK Power Networks continues to be listed in the Sunday Times' Top 25 Best Big Companies to Work For, and made industry history by becoming first company to win Utility of the Year two years running (2015 and 2016, also 2012). The company invests more than £600 million in its electricity networks every year, offers extra help to vulnerable customers at times of need, and is undertaking trials to ensure that electricity networks support the transition to a low carbon future. It also moves cables and connects new electricity supplies. If you have a power cut ring 105, see www.ukpowernetworks.co.uk or tweet us @UKPowerNetworks Info@smartwires.com Photo - https://mma.prnewswire.com/media/1173557/Smart_Wires_UK_Power_Networks.jpg Related Links :https://www.smartwires.com

• 

  The Society For The Promotion Of Japanese Animation Announces First Ever Anime Expo Lite - A Virtual Japanese Pop Culture Event

  FREE Livestream Event to take place July 3 & 4 SANTA ANA, California, May 28, 2020 /PRNewswire/ -- The Society for the Promotion of Japanese Animation (SPJA) is thrilled to unveil its plans to offer Japanese pop culture fans from around the world an opportunity to experience all things anime from wherever they are with Anime Expo Lite. This FREE two-day livestream event will begin on July 3, proclaimed Anime Expo Day by the City of Los Angeles in 2015, and continue through July 4. The Society for the Promotion of Japanese Animation announces first ever Anime Expo, a Free virtual Japanese pop culture event July 3 & 4, 2020. Anime Expo Lite will feature content from industry partners such as Bushiroad, Crunchyroll, Pony Canyon, VIZ, and more! More exclusive content will be announced in the coming weeks. SPJA has also revealed the key art that was planned as the program guide cover for the since cancelled Anime Expo 2020, which now features the Anime Expo Lite logo instead. The AX mascot characters Ai and Xeno are pictured with the cast of The World End With You. "We are excited to be able to parlay the traditional Anime Expo into a virtual experience. Since 2017, AX has been livestreaming select panels as well as from the convention floor, so it is a natural transition for us to produce a virtual event. As everything in 2020 is different, we see a unique opportunity to be able to share our passion for Japanese pop culture not only with those that would have attended AX but now with any anime fan no matter where they live," said Ray Chiang, CEO of The Society for the Promotion of Japanese Animation, AX's organizer. "With our Anime Expo Lite line-up, we know fans will find plenty of events and special guests to entertain and keep them engaged." Fans can expect to see: Special Guests, including artist/character designer Yoshitaka Amano Panel discussions with industry leaders Industry announcements Live content Pre-taped content from global partners Q&As Giveaways For more information, and to keep up-to-date on Anime Expo Lite announcements, please sign-up here https://mailchi.mp/anime-expo/ax-lite-updates. For 29 years, AX has been the preeminent event featuring the newest anime films, television series, fashion, video games, manga, dance, music concerts, exhibitors and exclusive convention merchandise, all combined to deliver unforgettable experiences to fans of anime and Japanese pop culture. AX will return to the Los Angeles Convention Center July 2-5, 2021. For more information regarding Anime Expo please visit www.anime-expo.org. About SPJA SPJA is a non-profit organization dedicated to popularize and educate the American public about Japanese entertainment and pop culture, as well as provide a forum to facilitate communication between professionals and fans. For more information, please visit www.spja.org. About Anime Expo Anime Expo (AX) brings together fans and industry from Japan, the US, and all over the world for the largest celebration of Japanese pop culture in North America. Taking place every year since 1992, Anime Expo features the best in Japanese entertainment, music, fashion, and video games. For more information, visit www.anime-expo.org. Media Contacts: Don Williams Carol Knight The Frame Shop The Frame Shop don@frameshoppr.com carol@frameshoppr.com 760-707-4589 760-450-7475 Photo - https://mma.prnewswire.com/media/1173556/2020_Anime_Expo_World_Ends_With_You_Collaboration_Copyright__1.jpg Related Links :http://www.anime-expo.org

• 

  Nutanix Reports Third Quarter Fiscal 2020 Financial Results

  -- Increased Remote Work and Demand for “Zero Touch” IT Drove 18% YoY TCV Revenue Growth -- Delivered 84% of Billings from Subscription During Continued Transition to Subscription Business Model with 340 Basis Point YoY Improvement in Gross Margins -- Proactive Operating Expense Management Aided Bottom-Line Results SAN JOSE, Calif.--(BUSINESS WIRE)--Nutanix, Inc. (NASDAQ: NTNX), a leader in enterprise cloud computing, today announced financial results for the third quarter of fiscal 2020 ended April 30, 2020. Q3 Fiscal 2020 Financial Highlights Revenue: $318.3 million, up 11% year-over-year from $287.6 million in the third quarter of fiscal 20191 Billings: $383.5 million, up 11% year-over-year from $346.0 million in the third quarter of fiscal 20191 Software and Support (TCV)2 Revenue: $314.5 million, up 18% year-over-year from $265.8 million in the third quarter of fiscal 2019 Software and Support (TCV)2 Billings: $379.7 million, up 17% year-over-year from $324.2 million in the third quarter of fiscal 2019 Gross Margin: GAAP gross margin of 77.3%, up from 73.9% in the third quarter of fiscal 2019; Non-GAAP gross margin of 80.7%, up from 77.1% in the third quarter of fiscal 2019 Net Loss: GAAP net loss of $240.7 million, compared to a GAAP net loss of $209.8 million in the third quarter of fiscal 2019; Non-GAAP net loss of $135.2 million, compared to a non-GAAP net loss of $103.0 million in the third quarter of fiscal 2019 Net Loss Per Share: GAAP net loss per share of $1.23, compared to a GAAP net loss per share of $1.15 in the third quarter of fiscal 2019; Non-GAAP net loss per share of $0.69, compared to a non-GAAP net loss per share of $0.56 in the third quarter of fiscal 2019 Cash and Short-term Investments: $732.1 million, down from $940.8 million in the third quarter of fiscal 2019 Deferred Revenue: $1.12 billion, up 34% from the third quarter of fiscal 2019 Operating Cash Flow: Use of $84.9 million, compared to use of $36.5 million in the third quarter of fiscal 2019 Free Cash Flow: Use of $117.5 million, compared to use of $58.9 million in the third quarter of fiscal 2019 Reconciliations between GAAP and non-GAAP financial measures and key performance measures are provided in the tables of this press release. “We are pleased to have delivered a solid quarter, particularly in light of the global uncertainty caused by the COVID-19 pandemic,” said Dheeraj Pandey, Chairman, Co-Founder and CEO of Nutanix. “We are delighted to be in a position to support our customers with mission-critical solutions as they navigate the rapidly changing landscape of the future of work. Our near-term focus is on thoughtful cash and expense management, while proactively preparing to emerge from this time with the ability to drive long-term growth and scale our business with the market.” “By adapting quickly to a changing work environment, we were able to meet or exceed our anticipated third quarter results despite the challenging macroeconomic conditions,” said Duston Williams, CFO of Nutanix. “We have also taken proactive measures to manage our operating expenses, which will help meaningfully decrease our cash usage from here and enhance our financial flexibility going forward. While the duration and impact of the pandemic remain uncertain, we are confident that Nutanix is well-positioned to manage the business through this period and will emerge a stronger company with the help of our subscription transition.” Recent Company Highlights Reached 84 Percent of Billings from Subscription: Nutanix continued its transition to a subscription-based business model, with subscription billings up 43% year-over-year to $321 million, representing 84% of total billings, and subscription revenue up 55% year-over-year to $261 million, representing 82% of total revenue. Expanded Customer Base: Nutanix ended the third quarter of fiscal 2020 with 16,580 end-customers. Third quarter customer wins included the following Global 2000 companies: Bausch Health Companies, Inchcape, LabCorp, Orient Securities Co., and more. Launched Nutanix FastTrack for VDI: To assist partners and customers urgently expanding remote workforces, Nutanix launched FastTrack for VDI, which includes pre-sized configurations for a range of user types designed to ship quickly, as well as remote services to enable rapid deployment of users, and incentives to enhance partner profitability. Partnered with Wipro to Announce Digital Database Services Powered by Nutanix Era: This joint solution from Wipro, powered by Nutanix, empowers customers to consolidate their database workloads onto a shared infrastructure to manage database sprawl. The offering provides better efficiency, agility, cost-effectiveness, and scalability by automating and simplifying database administration. Delivered Invisible Infrastructure for Big Data and Analytics: The Nutanix platform now includes new features for big data and analytics applications. The company released Nutanix Objects 2.0, including the ability to manage object data across multiple clusters for achieving massive scale, as well as formal Splunk SmartStore certification. The enhancements add to a cloud platform that is already optimized for big data, to deliver performance and increased scale, while also reducing cost by maximizing existing, unused resources. Recognized as a Gartner Peer Insights Customers’ Choice Vendor for Hyperconverged Infrastructure (HCI)3: Nutanix has been recognized as a Customers’ Choice Vendor for the second year in a row, with an average score of 4.7 out of 5. This recognition is based on customer feedback in the past year across multiple vendors in the hyperconverged infrastructure industry. Achieved FedRAMP Authorization for Xi Government Cloud: Nutanix Xi Government Cloud achieved the Federal Risk and Authorization Management Program (FedRAMP) Authorized designation at the Moderate security impact level. Xi Government Cloud includes Xi Frame, a multi-cloud Desktop as a Service (DaaS) platform, and Xi Beam, a hybrid cloud cost governance tool. This allows Nutanix to deliver new solutions to federal agencies that need to quickly and securely expand telework capabilities, while also managing the costs and governance of their cloud resources. Simplified Advanced Disaster Recovery: Nutanix announced several new capabilities to its HCI software and AHV hypervisor to protect business-critical applications. These include advanced automation for recovering applications and data, support for seamless multi-site DR, synchronous replication for AHV, and a near-zero data loss with near sync replication with an RPO of only about 20 seconds, the only HCI vendor to do so. Streamlined IT Operations with Automation: The company expanded integration with ServiceNow, as well as introduced new capabilities in Nutanix Calm, its automation and management solution for DevOps. As customers look to streamline their IT operations and costs during this difficult time, these new features will help customers to simplify and automate infrastructure, application, and cloud management even further. Announced Nutanix Worldwide Special Financial Assistance Program: Nutanix demonstrated support for its partners with extended payment terms to help them sustain business operations during the rapidly changing macroeconomic environment. Additionally, Nutanix increased investments in partner learning and development with free certification exams for partners through July 2020. Won Top Rated Product Award for AOS: Nutanix AOS was recognized by Trust Radius as a Top Rated Product in the Server Virtualization and Virtual Desktop Infrastructure category. Top Rated awards showcase top products based solely on user feedback and satisfaction scores. Partnered with Avid to Deliver First HCI Platform for Media and Entertainment: Nutanix hyperconverged infrastructure software was recently certified to run with Avid Media Composer video editing software and the Avid MediaCentral media collaboration platform. Nutanix is the first HCI-powered private cloud solution to be certified for Avid products, offering a fully integrated solution for any Avid environment with the hardware platform of choice, built-in hypervisor, and one-click management. Strengthened Board of Directors with Veteran Technology Leader: The company recently appointed industry veteran, Sohaib Abbasi, to its Board of Directors. The former Informatica CEO and Oracle executive brings deep technology and leadership experience to the Nutanix Board. Fiscal 2020 Financial Outlook Given the uncertainty created by the COVID-19 pandemic, and as previously announced on May 5, 2020, Nutanix has withdrawn its guidance for fiscal 2020, which was originally provided on February 26, 2020, as well as its business model targets for calendar 2021, which were presented during its Investor Day in March 2019. Nutanix plans to resume providing formal guidance when visibility improves. Supplementary materials to this earnings release, including the company’s third quarter fiscal 2020 earnings presentation, can be found at https://ir.nutanix.com/company/financial. 1Reflects total billings/revenue compression from the company’s ongoing transition to subscription and the significant reduction of hardware billings/revenue. 2TCV, or Total Contract Value, for any given period is defined as the total software and support revenue or total software and support billings, as applicable, during such period, which excludes revenue and billings associated with pass-through hardware sales during the period. 3Ratings and reviews current as of March 24, 2020. Gartner Peer Insights Customers’ Choice constitute the subjective opinions of individual end-user reviews, ratings, and data applied against a documented methodology; they neither represent the views of, nor constitute an endorsement by, Gartner or its affiliates. Webcast and Conference Call Information Nutanix executives will discuss the company’s third quarter fiscal 2020 financial results on a conference call at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time today. To listen to the call via telephone, dial 1-833-968-2186 in the United States or 1-825-312-2107 from outside the United States. The conference ID is 1473679. This call will be webcast live and available to all interested parties on our Investor Relations website at ir.nutanix.com. Shortly after the conclusion of the conference call, a replay of the audio webcast will be available on the Nutanix Investor Relations website. A telephonic replay will be available for one week by calling 1-800-585-8367 or 1-416-621-4642, and entering the conference ID 1473679. Non-GAAP Financial Measures and Other Key Performance Measures To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use the following non-GAAP financial and other key performance measures: billings, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP net loss, non-GAAP net loss per share, free cash flow, software and support revenue (or TCV revenue), subscription revenue, software and support billings (or TCV billings), subscription billings, and professional services billings. In computing these non-GAAP financial measures and key performance measures, we exclude certain items such as stock-based compensation and the related income tax impact, costs associated with our acquisitions (such as amortization of acquired intangible assets, income tax-related impact, and other acquisition-related costs), impairment of operating lease-related assets, amortization of debt discount and issuance costs, other non-recurring transactions and the related tax impact, and the revenue and billings associated with pass-through hardware sales. Billings is a performance measure which we believe provides useful information to investors because it represents the amounts under binding purchase orders received by us during a given period that have been billed, and we calculate billings by adding the change in deferred revenue between the start and end of the period to total revenue recognized in the same period. Free cash flow is a performance measure that we believe provides useful information to our management and investors about the amount of cash generated by the business after necessary capital expenditures, and we define free cash flow as net cash (used in) provided by operating activities less purchases of property and equipment. Non-GAAP gross margin, non-GAAP operating expenses, non-GAAP net loss, and non-GAAP net loss per share are financial measures which we believe provide useful information to investors because they provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures such as stock-based compensation expense that may not be indicative of our ongoing core business operating results. TCV revenue and TCV billings are performance measures that we believe provide useful information to our management and investors as they allow us to better track the true growth of our software business by excluding the amounts attributable to the pass-through hardware sales that we use to deliver our solutions. Subscription revenue, subscription billings, and professional services billings are performance measures that we believe provide useful information to our management and investors as they allow us to better track the growth of the subscription-based portion of our business, which is a critical part of our business plan. We use these non-GAAP financial and key performance measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. However, these non-GAAP financial and key performance measures have limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP. Billings, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP net loss, non-GAAP net loss per share, and free cash flow are not substitutes for total revenue, gross margin, operating expenses, net loss, net loss per share, or net cash (used in) provided by operating activities, respectively; subscription revenue, TCV revenue and TCV billings are not substitutes for total revenue; and subscription and professional services billings are not a substitute for subscription and professional services revenue. In addition, other companies, including companies in our industry, may calculate non-GAAP financial measures and key performance measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures and key performance measures as tools for comparison. We urge you to review the reconciliation of our non-GAAP financial measures and key performance measures to the most directly comparable GAAP financial measures included below in the tables captioned “Reconciliation of Revenue to Billings,” “Disaggregation of Revenue and Billings,” “Reconciliation of Subscription and Professional Services Revenue to Subscription and Professional Services Billings,” “Reconciliation of Software and Support Revenue (TCV Revenue) to Software and Support Billings (TCV Billings),” “Reconciliation of GAAP to Non-GAAP Profit Measures,” and “Reconciliation of GAAP Net Cash Provided By Operating Activities to Non-GAAP Free Cash Flow,” and not to rely on any single financial measure to evaluate our business. Forward-Looking Statements This press release contains express and implied forward-looking statements, including, but not limited to, statements regarding: our business plans, initiatives and objectives, including changes we have made or anticipate making in response to the COVID-19 pandemic, our ability to manage our business during the pandemic, and the position we anticipate being in following the pandemic; our ability to execute such plans, initiatives and objectives in a timely manner, and the benefits and impact of such plans, initiatives and objectives, including our ability to manage our expenses and decrease our cash usage in future periods; our customer needs and our response to those needs; the benefits and capabilities of our platform, products, services and technology; our plans and expectations regarding new products, services, product features and technology, including those that are still under development or in process; our plans and timing for, and the success and impact of, our transition to a subscription-based business model; our plans to provide financial guidance in the future; and the timing and potential impact of the COVID-19 pandemic on our business, operations and financial results, including the actions we have taken to manage operating expenses. These forward-looking statements are not historical facts and instead are based on our current expectations, estimates, opinions, and beliefs. Consequently, you should not rely on these forward-looking statements. The accuracy of such forward-looking statements depends upon future events and involves risks, uncertainties, and other factors, including factors that may be beyond our control, that may cause these statements to be inaccurate and cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by such statements, including, among others: failure to successfully implement or realize the full benefits of, or unexpected difficulties or delays in successfully implementing or realizing the full benefits of, our business plans, initiatives and objectives; the timing, breadth, and impact of the COVID-19 pandemic on our business, operations, and financial results, as well as the impact on our customers, partners, and end markets; failure to timely and successfully meet our customer needs; delays in or lack of customer or market acceptance of our new products, services, product features or technology; delays or unexpected accelerations in the transition to a subscription-based business model; the rapid evolution of the markets in which we compete; our ability to achieve, sustain and/or manage future growth effectively; factors that could result in the significant fluctuation of our future quarterly operating results, including, among other things, anticipated changes to our revenue and product mix, including changes as a result of our transition to a subscription-based business model, which will slow revenue growth during such transition and make forecasting future performance more difficult, the timing and magnitude of orders, shipments and acceptance of our solutions in any given quarter, our ability to attract new and retain existing end-customers, changes in the pricing of certain components of our solutions, and fluctuations in demand and competitive pricing pressures for our solutions; the introduction, or acceleration of adoption of, competing solutions, including public cloud infrastructure; and other risks detailed in our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2020, filed with the U.S. Securities and Exchange Commission, or the SEC, on March 5, 2020. Additional information will also be set forth in our Quarterly Report on Form 10-Q that will be filed for the fiscal quarter ended April 30, 2020, which should be read in conjunction with this press release and the financial results included herein. Our SEC filings are available on the Investor Relations section of the company’s website at ir.nutanix.com and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release and, except as required by law, we assume no obligation, and expressly disclaim any obligation, to update, alter or otherwise revise any of these forward-looking statements to reflect actual results or subsequent events or circumstances. About Nutanix Nutanix is a global leader in cloud software and a pioneer in hyperconverged infrastructure solutions, making computing invisible anywhere. Organizations around the world use Nutanix software to leverage a single platform to manage any app at any location for their private, hybrid and multi-cloud environments. Learn more at www.nutanix.com or follow us on Twitter @nutanix. © 2020 Nutanix, Inc. All rights reserved. Nutanix, the Nutanix logo, and all Nutanix product and service names mentioned herein are registered trademarks or trademarks of Nutanix, Inc. in the United States and other countries. All other brand names mentioned herein are for identification purposes only and may be the trademarks of their respective holder(s). This press release contains links to external websites that are not part of Nutanix.com. Nutanix does not control these sites and disclaims all responsibility for the content or accuracy of any external site. Our decision to link to an external site should not be considered an endorsement of any content on such a site. NUTANIX, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)   As of   July 31,2019   April 30,2020   (in thousands) Assets       Current assets:       Cash and cash equivalents $ 396,678     $ 262,331   Short-term investments 512,156     469,806   Accounts receivable, net 245,475     236,690   Deferred commissions—current 46,238     63,177   Prepaid expenses and other current assets 74,665     63,189   Total current assets 1,275,212     1,095,193   Property and equipment, net 136,962     149,688   Operating lease right-of-use assets —     132,519   Deferred commissions—non-current 107,474     137,598   Intangible assets, net 66,773     53,738   Goodwill 185,180     185,260   Other assets—non-current 14,441     19,345   Total assets $ 1,786,042     $ 1,773,341           Liabilities and Stockholders’ Equity (Deficit)       Current liabilities:       Accounts payable $ 74,047     $ 68,232   Accrued compensation and benefits 99,804     85,641   Accrued expenses and other current liabilities 28,797     21,829   Deferred revenue—current 396,667     503,311   Operating lease liabilities—current —     34,371   Total current liabilities 599,315     713,384   Deferred revenue—non-current 513,377     618,749   Operating lease liabilities—non-current —     123,470   Convertible senior notes, net 458,910     482,199   Other liabilities—non-current 27,547     19,578   Total liabilities 1,599,149     1,957,380   Stockholders’ equity (deficit):       Common stock 5     5   Additional paid-in capital 1,835,528     2,151,175   Accumulated other comprehensive income 669     1,625   Accumulated deficit (1,649,309 )   (2,336,844 ) Total stockholders’ equity (deficit) 186,893     (184,039 ) Total liabilities and stockholders’ equity (deficit) $ 1,786,042     $ 1,773,341   NUTANIX, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)   Three Months EndedApril 30,   Nine Months EndedApril 30,   2019     2020     2019     2020     (in thousands, except per share data) Revenue:               Product $ 184,794     $ 180,756     $ 646,072     $ 586,747   Support, entitlements and other services 102,830     137,517     290,195     393,061   Total revenue 287,624     318,273